Jon Hamilton
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
Stay updated with breaking news from Jon Hamilton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.
AILSA CHANG, HOST: Doctors can now prescribe a controversial new drug to their patients with Alzheimer's disease. But even medical experts are still trying to figure out which patients should get the drug and how to use it safely. NPR's Jon Hamilton reports from the Alzheimer's Association International Conference in Denver. JON HAMILTON, BYLINE: The drug, called Aduhelm, received a conditional approval from the Food and Drug Administration in June. The approval came despite conflicting evidence on whether the drug actually slows the progression of Alzheimer's. Since then, some experts have s...